Shelly Malhotra Selected Research

Duration of Therapy

9/2019

Estimating the impact of a novel drug regimen for treatment of tuberculosis: a modeling analysis of projected patient outcomes and epidemiological considerations.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shelly Malhotra Research Topics

Disease

3	Tuberculosis (Tuberculoses) 01/2023 - 09/2019
2	COVID-19 01/2023 - 01/2023
2	Extensively Drug-Resistant Tuberculosis 01/2022 - 12/2021
1	HIV Infections (HIV Infection) 11/2023
1	Communicable Diseases (Infectious Diseases) 01/2023

Drug/Important Bio-Agent (IBA)

2	Linezolid (Zyvox)FDA Link 01/2022 - 12/2021
2	pretomanidIBA 01/2022 - 12/2021
2	bedaquiline (R207910)IBA 01/2022 - 12/2021
1	Broadly Neutralizing AntibodiesIBA 11/2023
1	Guanosine Diphosphate (GDP)IBA 11/2023
1	Monoclonal AntibodiesIBA 01/2023
1	VaccinesIBA 01/2023
1	FluoroquinolonesIBA 12/2020
1	Rifampin (Rifampicin)FDA LinkGeneric 09/2019

Therapy/Procedure

1	Duration of Therapy 09/2019